Qiagen Q1 Earnings Tops Estimates As Growth In Non-COVID-19 Products Boost RevenuesBenzinga • 05/04/21
QIAGEN Exceeds Outlook in First Quarter 2021 Results, Reaffirms Sales Growth and Profitability Outlook for Full-Year 2021Business Wire • 05/03/21
QIAGEN Announces EZ2 Connect Instrument Line for Automated Sample Processing in Research, Forensics and DiagnosticsBusiness Wire • 04/29/21
QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early diagnosis of Lyme BorreliosisBusiness Wire • 04/21/21
QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing CapacityBusiness Wire • 04/20/21
QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic SurveillanceBusiness Wire • 04/06/21
QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 PortfolioBusiness Wire • 03/29/21
QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital DiagnosticsBusiness Wire • 03/03/21
QIAGEN Launches QIAcube Connect MDx Platform for Automated Sample Processing in Diagnostic LabsBusiness Wire • 03/02/21
QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO's VGX-3100 for Advanced Cervical DysplasiaBusiness Wire • 02/24/21
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/10/21